ERT Launches Phase I Site Certification Program


Applied Clinical Trials

ERT announced it has launched a certification program for Phase I investigative sites conducting cardiac safety studies. This program trains sites to collect precise cardiac safety data by using ERT’s proprietary Expert Precision QT approach so that trial sponsors and CROs can determine the safety of their compounds earlier in development, which can save significant time and money. 

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.